Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 6.88% | |
| Drug Manufacturers - General | 34.46% | 14.07% | |
| Healthcare Plans | 13.39% | -0.25% | |
| Medical Devices | 12.14% | 2.17% | |
| Biotechnology | 12.06% | 5.08% | |
| Diagnostics & Research | 10.88% | 1.74% | |
| Medical Instruments & Supplies | 6.82% | 10.01% | |
| Medical Care Facilities | 3.00% | 18.12% | |
| Drug Manufacturers - Specialty & Generic | 2.75% | -1.91% | |
| Medical Distribution | 2.32% | 10.38% | |
| Health Information Services | 2.04% | 7.41% | |
| Pharmaceutical Retailers | 0.14% | -57.21% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 862.29 | 908.48 | 11.63% | Buy | ||||
| 559.92 | 615.25 | 7.72% | Buy | ||||
| 154.56 | 171.82 | 5.57% | Buy | ||||
| 125.64 | 143.20 | 4.77% | Buy | ||||
| 173.18 | 184.72 | 4.58% | Buy | ||||
| 539.92 | 624.92 | 3.09% | Buy | ||||
| 248.12 | 272.04 | 2.75% | Buy | ||||
| 103.66 | 124.80 | 2.70% | Buy | ||||
| 334.50 | 319.72 | 2.69% | Buy | ||||
| 29.70 | 31.64 | 2.52% | Hold |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 148.50 | 39.084B | 0.09% | ||
| 271.92 | 20.601B | 0.10% | ||
| 144.85 | 7.363B | 0.45% | ||
| 97.86 | 7.126B | 0.35% | ||
| 56.81 | 5.134B | 0.40% |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 223.52 | 47.799B | 0.30% | ||
| 94.26 | 47.799B | 0.30% | ||
| 135.52 | 20.601B | 0.10% | ||
| 97.01 | 14.902B | 0.80% | ||
| 96.71 | 14.902B | 0.80% |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Weekly Stock List
Dividend income is often overlooked amid gyrations in the stock market. But dividends are an important element of return. Dividend income accounted for 42% of the total return of the S&P 500 between 1930 and 2012, according to Hartford Funds. And that's just the average. In some of those decades, dividends accounted for more than 50% of total returns and even 100% of returns. More recently, dividends have accounted for a smaller portion of returns, at around 15%-20%. Not for nothing, in 2022, dividend payments softened the blow when most market indices turned bearish as the Federal Reserve hiked interest rates. Not all dividends are created equal, though, and it is important to understand the difference between the two main categories: high-yield stocks and dividend-growth stocks. High-yield stocks typically have dividends that pay out in the 5%-8% range. Though the income appears attractive, the share prices of high-yield stocks could signal some risks. Dividend-growth stocks typically have lower yields, often in the 1.0%-2.5% range. But the lower-yielding dividends are not likely to be a huge component of cash flow, leaving management teams with other value-additive options for deploying cash -- such as share buybacks, M&A, the repayment of debt, or reinvestment in the core business. Below is a partial list of Argus BUY-rated stocks that are included in our June Dividend Growth Theme Model Portfolio.
Analyst Report: Elevance Health Inc
Elevance is a health benefits company. The company operates through two segments: Health Benefits and Carelon Services. The Health Benefits segment provides insurance to members to individuals, employer groups, Medicaid, Medicare Advantage and the Federal sector. Carelon is composed of Carelon Rx, which provides prescription management services, and Carelon Services. The services include medical benefit and behavioral health management services. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance is headquartered in Indianapolis, Indiana. ELV is a component of the S&P 500.
RatingPrice TargetMarket Digest: FITB, HBAN, KR, NFLX, OMC, ELV
Big Tech earnings start this week, with a broad range of companies reporting. As well, key inflation data is due as is an update on GDP. Last week, markets were volatile and there was a theme of rotation out of Information Technology and into small caps. The Dow Jones Industrial Average was up 0.7% for the week, the S&P 500 lost 2%, and the Nasdaq fell 3.7%. Year to date, the Dow is higher by 7%, the S&P is up 15%, and the Nasdaq is 18% ahead. On the economic calendar, Friday is the big day, with fresh inflation data. Economists are looking for more evidence that inflation is tracking lower. If it is, that should help build the case for a Fed rate cut. This week, the data comes in the form of the Personal Consumption Expenditures Index (PCE). In May, both PCE and Core PCE came in at 2.6%. We expect both to slow to 2.4% for June. In other economic news, Existing Home Sales data will be reported on Tuesday. On Wednesday, New Home Sales come out. On Thursday, GDP and Durable Goods Orders hit the tape. And on Friday, Personal Income and Personal Spending will be updated. On the earnings calendar, Monday brings news from Verizon. On Tuesday, Alphabet, Tesla, Comcast, Coca-Cola, GE Aerospace, General Motors, Philip Morris, UPS, and Lockheed Martin. On Wednesday, IBM, AT&T, Chipotle, and Ford. On Thursday, Northrop Grumman, American Airlines, Southwest Airlines, Juniper Networks, AstraZeneca, and Union Pacific. And on Friday, 3M, Bristol Myers Squibb, Colgate-Palmolive, and Charter Communications. Earnings are coming in 11.1% higher this quarter than a year ago, but only 14% of S&P 500 companies have reported so far. Expectations are for 8%-12% earnings growth in the second quarter. This follows 8% growth in 1Q and 10% in 4Q23. At Argus, we forecast that full-year 2024 EPS will come in 8%-9% better than last year. Last week, mortgage rates fell 12 basis points to 6.77% for the average 30-year fixed-rate mortgage. Gas prices rose a penny to $3.50 per gallon for the average price of regular gas. The Atlanta Fed GDPNow indicator is forecasting for 2Q and calls for expansion of 2.7%. The Cleveland Fed CPINow indicator forecasts 3.01% for July CPI. The next Fed rate decision is on July 31, with odds at 4% for a cut. Then in mid-September, there is a big jump in odds for a cut, to 98%. That spike follows that recent news that inflation is tracking down and the labor market is showing some weakness. As the probability is so high for a rate cut at the September meeting, the odds have jumped to 60% for a second cut in November. In December 18, odds increase to 94% for that second cut. All of this data is according to the CME FedWatch Tool.
Daily – Vickers Top Buyers & Sellers for 07/22/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.



















